http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Clever Leaves (CLVR) Announces 1:30 Reverse Split
-
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
-
Clever Leaves Reports Second Quarter 2023 Results
-
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET
-
Clever Leaves (CLVR) Announces Partnership with Colombian Flower
-
Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
-
Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International Subsidiary
-
Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
-
Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023
-
Clever Leaves to Present at Canaccord Genuity’s 7th Annual Global Cannabis Conference
-
Clever Leaves Reports First Quarter 2023 Results
-
Clever Leaves to Hold First Quarter 2023 Conference Call on Thursday, May 11, 2023 at 5:00 p.m. ET
-
Clever Leaves and Praetorian Announce Exclusive Agreement to Produce Cannabis Genetics in Colombia
-
Clever Leaves to Present at Sequire Cannabis & Psychedelics Conference on April 5, 2023 at 2:30 p.m. ET
-
Clever Leaves Reports Fourth Quarter and Full Year 2022 Results
-
Clever Leaves Reschedules Fourth Quarter and Full Year 2022 Conference Call to Thursday, March 30, 2023 at 5:00 p.m. ET
-
Clever Leaves to Hold Fourth Quarter and Full Year 2022 Conference Call on Thursday, March 23, 2023 at 5:00 p.m. ET
-
Clever Leaves Announces Wind-Down of Portugal Operations as Part of Ongoing Restructuring Initiatives
-
Clever Leaves Reports Third Quarter 2022 Results
-
Clever Leaves Partners with Anden Naturals to Bring Pharmaceutical-Grade Cannabis to Patients in Peru
-
Clever Leaves to Hold Third Quarter 2022 Conference Call on Wednesday, November 9, 2022 at 5:00 p.m. ET
-
Clever Leaves Partners With House of Kush for International Expansion
-
Clever Leaves Reports Second Quarter 2022 Results
-
Clever Leaves to Hold Second Quarter 2022 Conference Call on August 11, 2022 at 5:00 p.m. ET
-
Clever Leaves Announces First Export to Israeli Partner InterCure
-
Clever Leaves strengthens German presence through expanded Cantourage partnership
-
Clever Leaves (CLVR) and Cantourage Expand Partnership for Distribution of Medical Cannabis in Germany
-
Cantourage and Clever Leaves intensify strategic partnership for distribution of medical cannabis in Germany
-
Clever Leaves Reports First Quarter 2022 Results
-
Clever Leaves to Participate in Upcoming May Investor Conferences
-
Clever Leaves to Hold First Quarter 2022 Conference Call on May 12, 2022 at 5:00 p.m. ET
-
Clever Leaves (CLVR) German Subsidiary Becomes a Fully Licensed Medical Cannabis Distributor in Germany
-
Clever Leaves Germany GmbH Becomes a Fully Licensed Medical Cannabis Distributor in Germany
-
Clever Leaves (CLVR) Announces Two-Year Supply Agreement with Biom Therapeutics
-
Clever Leaves Strengthens Its Presence in the U.S. Through Partnership With Biom Therapeutics
-
Clever Leaves to Present at Upcoming April Investor Conferences
-
Clever Leaves Ready to Export Dried Flower From Colombia
-
Clever Leaves Reports Fourth Quarter and Full Year 2021 Results
-
InterCure and Clever Leaves Announce International Strategic Partnership
-
InterCure Ltd (INCR) Enters Partnership with Clever Leaves (CLVR)
-
InterCure and Clever Leaves Announce International Strategic Partnership
-
Clever Leaves (CLVR) Appoints William Muecke to its Board
-
Clever Leaves Appoints William Muecke to Board of Directors
-
Clever Leaves to Hold Fourth Quarter and Full Year 2021 Conference Call on March 24, 2022 at 5:00 p.m. ET
-
Clever Leaves to Present at the 34th Annual ROTH Conference
-
Clever Leaves Partners With FoliuMed to Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany
-
The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia
-
Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa Verde
-
Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership
-
Clever Leaves (CLVR) Announces $3.6M Sales Agreement with Cannatrek

